Showing 1591-1600 of 4166 results for "".
Building Momentum in Your Contact Lens Business
https://modernod.com/podcasts/the-mod-pod/building-momentum-in-your-contact-lens-business/36871/Darryl Glover Jr., OD; Britt E. Gustafson, OD; and Selina R. McGee, OD, FAAO, discuss contact lenses as an integral pillar of their practice success. They review how technology, such as Alcon’s WaterInnovations™ portfolio, helps them differentiate their practice from competitors by customizing fitZeiss MEL 90 Approved by FDA
https://modernod.com/podcasts/eyewire-news-the-podcast/zeiss-mel-90-approved-by-fda/37068/Zeiss receives a major approval for its new excimer laser; Bausch + Lomb makes two deals to bolster its pipeline in glaucoma and geographic atrophy; and Rayner announces the full European launch of its RayOne Galaxy IOLs. Learn more about your ad choices. Visit megaphone.fm/adchoicesEye Trauma • Nutrition and Glaucoma
https://modernod.com/podcasts/the-mod-pod/eye-trauma-nutrition-and-glaucoma/36869/In The MOD Pod's first episode of 2025 Cecelia Koetting, OD, FAAO, Dipl ABO, chats with her former resident Brooke Hyde, OD, FAAO, about what it's like dealing with ocular emergencies. Dr. Hyde explains how treating these cases can be a practice-builder and shares helpful tips to keep in mind when d2024 Year in Review — Part 1
https://modernod.com/podcasts/eyewire-news-the-podcast/2024-year-in-review-part-1/37064/In today’s broadcast, we look back at the top stories from the first half of 2024. There were several advancements made during the first six months., including the approval of an excimer laser platform; the global adoption of sustained-released anti-VEGF treatments for retinal diseases; the rolloutB+L Bolsters Glaucoma Offerings with Elios Acquisition
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-bolsters-glaucoma-offerings-with-elios-acquisition/37063/Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoicesPhase 3 Results for Novel Sedation Tablet
https://modernod.com/podcasts/eyewire-news-the-podcast/phase-3-results-for-novel-sedation-tablet/37062/New phase 3 data is released for a non-opioid sedation tablet; the first patient is dosed in the phase 3 trial of EyePoint’s wet AMD candidate; and Outlook receives a reimbursement decision in the UK for its wet AMD treatment. Learn more about your ad choices. Visit megaphone.fm/adchoicesMeibomian Gland Probing
https://modernod.com/podcasts/to-the-point/meibomian-gland-probing/36941/This month on To the Point, learn about meibomian gland probing in patients with dry eye with Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO. Their guest, Rana Taji, OD, MSc, FAAO, explains what it is, how to do it, why to do it, and more.Phakic IOL for Presbyopia Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/phakic-iol-for-presbyopia-approved-in-europe/37061/A new phakic IOL for presbyopia is approved in Europe; Nidek launches its preloaded Toric IOL Injection System internationally; and the FDA cleared a novel device for the treatment of Meibomian Gland Dysfunction. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: OWL Celebrates 20th Anniversary
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-owl-celebrates-20th-anniversary/37060/Executives from Ophthalmic World Leaders discuss the history and goals of thee organization as it celebrates its 20th anniversary. Learn more about your ad choices. Visit megaphone.fm/adchoicesLLLT and AMD: Your Questions Answered
https://modernod.com/topics/retina/lllt-and-amd-your-questions-answered/37350/Joseph J. Allen, OD, FAAO, Dipl ABO, gives an overview of a recently FDA-authorized low-level light therapy, or photobiomodulation, device, the Valeda Light Delivery System (LumiThera). He explains the device’s unique mechanism of action for treating age-related macular degeneration, reviews promisi